DEUTSCHE BANK AG\ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$844,752
+13.7%
860,000
+14.7%
0.00%
Q2 2022$743,000
-45.0%
750,000
-44.4%
0.00%
-100.0%
Q1 2022$1,350,000
+7.7%
1,350,000
+12.5%
0.00%0.0%
Q4 2021$1,254,000
+2.1%
1,200,0000.0%0.00%0.0%
Q3 2021$1,228,000
-65.1%
1,200,000
-65.5%
0.00%
-50.0%
Q1 2021$3,523,000
-46.6%
3,481,000
-43.4%
0.00%
-50.0%
Q4 2020$6,595,000
-14.9%
6,146,000
-16.8%
0.00%
-20.0%
Q3 2020$7,753,000
+118.8%
7,389,000
+154.8%
0.01%
+66.7%
Q2 2020$3,544,000
-33.8%
2,900,000
-43.2%
0.00%
-40.0%
Q1 2020$5,352,000
+0.2%
5,107,000
+1.0%
0.01%
+66.7%
Q4 2019$5,343,000
+48.0%
5,058,000
+37.7%
0.00%0.0%
Q3 2019$3,609,000
-4.1%
3,672,000
+1.3%
0.00%
+50.0%
Q2 2019$3,762,000
-31.8%
3,624,000
-32.8%
0.00%
-33.3%
Q1 2019$5,519,000
+43.5%
5,395,000
+39.5%
0.00%0.0%
Q4 2018$3,845,000
-77.9%
3,868,000
-76.3%
0.00%
-40.0%
Q3 2018$17,414,000
-8.0%
16,340,000
-12.8%
0.01%0.0%
Q2 2018$18,931,000
+217.6%
18,740,000
+195.1%
0.01%
+66.7%
Q1 2018$5,960,000
-24.8%
6,351,000
-20.2%
0.00%
-40.0%
Q4 2017$7,925,000
+143.1%
7,956,000
+147.2%
0.01%
+150.0%
Q3 2017$3,260,0003,218,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2018
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 16,298,000$15,340,0001.64%
ZAZOVE ASSOCIATES LLC 25,540,000$24,103,0001.55%
PIER 88 INVESTMENT PARTNERS LLC 3,030,000$2,844,0001.36%
Jabre Capital Partners S.A. 5,500,000$5,184,0001.12%
Sonora Investment Management, LLC 7,100,000$6,681,214,0001.06%
ADVENT CAPITAL MANAGEMENT /DE/ 43,256,000$40,793,0000.80%
Opera Trading Capital 10,000,000$9,370,0000.72%
AQR Arbitrage LLC 52,575,000$49,486,0000.57%
Neuberger Berman Group LLC 5,000,000$469,375,0000.54%
CQS Cayman LP 12,000,000$11,322,0000.52%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders